From the Journals

Guideline Reclassifies 11% of Patients With Stage 1 Hypertension

Risk-based criteria reduced automatic treatment eligibility among older adults without high-risk comorbidities.

Share

  • 1

    The 2025 guideline shifts from age-based to individualized assessment for hypertension treatment.

  • 2

    240,000 US adults aged 65-79 may be reclassified as ineligible for pharmacotherapy.

  • 3

    11% of untreated patients no longer qualify for immediate drug therapy.

  • 4

    Eligibility now based on a 10-year cardiovascular risk of 7.5% or high-risk comorbidities.

  • 5

    Study analyzed data from the National Health and Nutrition Examination Survey (2013-2020).

  • 6

    Majority of patients remaining eligible have high-risk comorbidities.

Original Source(s)

Guideline Reclassifies 11% of Patients With Stage 1 Hypertension

  • by Kerri Miller

  • March 17, 2026

Related Content

Global Cardiac Imaging Radiation Varies Widely

International study of more than 19,000 patients finds substantial differences in radiation exposure from coronary artery disease imaging across modalities, regions, and income levels.

Childhood Tooth Decay Linked to Heart Risk 

Danish study points to the importance of oral health interventions to protect future cardiovascular health

  • March 11, 2026

  • 2 min
AI-Selected Trial Candidates are More Diverse

Could artificial intelligence-enabled medical chart review improve the speed, accuracy, and equity of study enrollment?

  • March 10, 2026

  • 3 min